Biodexa Pharmaceuticals annual shares outstanding
2020
2021
Biodexa Pharmaceuticals Shares Outstanding History (BDRX)
Biodexa Pharmaceuticals reported 6.74B shares outstanding at the end of fiscal 2021.
View full Biodexa Pharmaceuticals company overviewBiodexa Pharmaceuticals annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2021 | 2021-12-31 | 6.74B | −306.8M | −4.35% |
| 2020 | 2020-12-31 | 7.05B | — | — |
Biodexa Pharmaceuticals quarterly shares outstanding
Q4.20
Q4.21
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q4 2021 | 2021-12-31 | 6.74B | — | — |
| Q4 2020 | 2020-12-31 | 7.05B | — | — |
Biodexa Pharmaceuticals shares outstanding trends
Across the available reported history, Biodexa Pharmaceuticals's shares outstanding moved from 7.05B to 6.74B, a change of −306.8M. The latest reported quarter, Q4 2021, shows 6.74B.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biodexa Pharmaceuticals filings at SEC.gov ↗